Literature DB >> 15181326

Time course from first symptom to the treatment of lung cancer in the Eastern Black Sea Region of Turkey.

Tevfik Ozlü1, Yilmaz Bülbül, Funda Oztuna, Gamze Can.   

Abstract

OBJECTIVES: To determine the delay between the onset and the diagnosis and treatment of patients with lung cancer in two cancer centres in the Eastern Black Sea Region of Turkey. SUBJECTS AND METHODS: The records of 226 patients (217 males, 9 females) were evaluated retrospectively for the dates noted for the onset of symptoms, first presentation to a physician, histopathological diagnosis and start of treatment. The median time intervals from the appearance of the first symptom to definitive diagnosis and treatment were calculated.
RESULTS: The patients presented to their physicians 30 (range 2-365) days after their complaints began. The time that elapsed between admission and histopathological diagnosis and between the diagnosis and initiation of therapy were 8 (range 1-210) and 17.5 days (range 0-206), respectively. The median time span from presentation to treatment was 30 days (range 1-253). There were no significant time interval differences between onset of symptoms and first presentation and the subsequent diagnostic and therapeutic processes for histopathology, stage of the tumour and treatment procedures (p > 0.05).
CONCLUSION: Reasons for the delayed treatment of lung cancer patients were late presentation to the physician and the long time interval between tissue diagnosis and treatment. This delay was mostly associated with a large number of patients and delayed appointments for imaging procedures--the result of organisational problems within the health services of Turkey. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2004        PMID: 15181326     DOI: 10.1159/000078318

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  6 in total

Review 1.  Defining timeliness in care for patients with lung cancer: a scoping review.

Authors:  Adnan Ansar; Virginia Lewis; Christine Faye McDonald; Chaojie Liu; Muhammad Aziz Rahman
Journal:  BMJ Open       Date:  2022-04-07       Impact factor: 2.692

2.  Personality Predictors of the Time Course for Lung Cancer Onset.

Authors:  Adam A Augustine; Randy J Larsen; Mark S Walker; Edwin B Fisher
Journal:  J Res Pers       Date:  2008-12

3.  Expression of miRNA-601 and PD-L1 among Iranian Patients with Lung Cancer and Their Relationship with Smoking and Mycoplasma Infection.

Authors:  Mahla Ganjali; Babak Kheirkhah; Kumarss Amini
Journal:  Cell J       Date:  2021-12-29       Impact factor: 2.479

4.  Assessment of Relationship of ABO Blood Groups in Oral Cancer Patients - A Retrospective Study.

Authors:  Pradhuman Verma; Avinash Kumar; Shantanu Dixit; Kratika Mohan; Nidhi Gupta; Gourab Mandal
Journal:  Ann Maxillofac Surg       Date:  2021-07-24

5.  Delays in Diagnosis and Treatment in Patients Underwent Endobronchial Ultrasound-Transbronchial Needle Aspiration (EBUS-TBNA).

Authors:  Emine Gülçek; Murat Yalçınsoy; İlham Gülçek; Arzu Nakış Güven; Hilal Ermiş; Zeynep Ayfer Aytemur
Journal:  Int J Clin Pract       Date:  2022-07-18       Impact factor: 3.149

6.  Cancer among syrian refugees living in Konya Province, Turkey.

Authors:  Tezer Kutluk; Mehmet Koç; İrem Öner; İbrahim Babalıoğlu; Meral Kirazlı; Sinem Aydın; Fahad Ahmed; Yavuz Köksal; Hüseyin Tokgöz; Mustafa Duran; Richard Sullivan
Journal:  Confl Health       Date:  2022-01-31       Impact factor: 2.723

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.